Alpha Tribe
FeedCompaniesMarket summaryAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
NC

Natural Capsules Limited

NATCAPSUQ·Pharmaceuticals

Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and DerivativesBusiness Overview: NCL is a WHO-GMP certified and ISO 9001, ISO 140001 compliance manufacturer of printed and unprinted hard two-piece Gelatin and Cellulose (HPMC : non-animal alternative) capsules for pharmaceutical and dietary supplement industries in various sizes of 00,...

103Announcements
09-09-2026Last filed
25Last 90 days
naturalcapsules.com

What Natural files

  • Others55
  • Updates14
  • Board Meeting10
  • Investor Meet10
  • Important5
  • PPTs4
Showing Important announcements (5)Clear filter
17-08-2026 · 06:57 pm

**NATCAPSUQ Governance Alert**: Independent Director Mr. Pramod Kasat has resigned from Natural Biogenex Private Limited, a key unlisted subsidiary of Natural Capsules Limited. He cited 'professional commitments' for his departure. **What it means for you**: This is a change in board oversight at a material subsidiary. While resignations are common,...

Read the full announcement→
PDF
31-07-2026 · 05:52 pm

**NATCAPSUQ Alert:** Natural Capsules' material unlisted subsidiary, Natural Biogenex Private Limited, has approved the allotment of 9,46,305 equity shares at ₹10 each through a Rights Issue, successfully raising ₹0.95 Cr. **Issue & Impact:** This capital infusion significantly strengthens the subsidiary's financial position, providing robust support for its ongoing operations and...

Read the full announcement→
PDF
29-07-2026 · 07:08 pm

**NATCAPSUQ Update:** Natural Capsules (NCL) has opted *not* to subscribe to the Rights Issue offered by its subsidiary, Natural Biogenex Private Limited. **The Issue & Impact:** NCL's non-participation will lead to a 2.18% dilution of its equity stake in Natural Biogenex, reducing it from 68.96% to 66.78%. Natural Biogenex will...

Read the full announcement→
PDF
04-08-2025 · 07:30 pm

Natural Capsules Limited has announced results from a board meeting held to approve the financial results for the quarter. On a standalone basis, revenue from operations grew to ₹44.24 Cr from ₹39.14 Cr year-on-year, with net profit increasing to ₹2.52 Cr from ₹1.46 Cr. Consolidated revenue rose to ₹45.20 Cr...

Read the full announcement→
PDF
04-08-2025 · 07:13 pm

Natural Capsules Limited's Board has approved the financial results for the quarter. This is a significant business development, as the impending release of these figures will offer retail investors crucial insights into the company's recent operational performance and financial health. Understanding these results is vital for assessing current business trends...

Read the full announcement→
PDF